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TO THE EDITOR
Polymorphic light eruption (PLE) is
acknowledged to be the most common
idiopathic photodermatosis, but epide-
miological data are sparse. From sur-
veys in 550 people in Perth and Ballarat
(Australia) and London (UK), PLE pre-
valence was estimated at 5.2, 3.6, and
14.8%, respectively (Pao et al., 1994),
whereas a postal questionnaire of 397
Swedish subjects showed symptoms of
PLE in 21% (Ros and Wennersten,
1986), and from 271 Boston (USA)
residents the prevalence of PLE was
estimated at 11% (Morison and Stern,
1982). These investigations led to the
assumption that PLE prevalence is
lower in countries nearer the equator,
whereas latitudes with higher seasonal
UV radiation modulation may predis-
pose to the condition. However, reli-
able data concerning this hypothesis
are lacking. In our large-scale cross-
sectional study, we assessed PLE pre-
valence in the adult population of six
European countries located from the
Mediterranean to Scandinavia.
Participating centers were university
dermatology departments in Athens
(Greece, NL 381), Besanc¸on (France,
471), Heidelberg (Germany, 49.51),
Leiden (The Netherlands, 521), Man-
chester (UK, 53.51), and Turku (Finland,
60.51). All subjects were indoor work-
ers, predominantly hospital staff,
whereas factory workers were included
in Heidelberg. Interviewees completed
a questionnaire under the supervision
of an investigator at each center. A
short (one-page) questionnaire was de-
veloped to encourage high response
(Figure S1). The first part of this ques-
tionnaire asked questions regarding
skin type, age, and sex, together with
the central question, ‘‘Do you get an
itching rash/abnormal skin after short
sun exposures, which you do not regard
as sunburn?’’ Interviewees answering
‘‘yes’’ continued the questionnaire,
including questions on occurrence
during springtime and sunny holidays,
age at first appearance, timing of
appearance after sun exposure, and
duration. Ethics approval was gained
at participating institutions, informed
consent was obtained, and the study
adhered to the Declaration of Helsinki
Principles. Data were collected
from March 2003 to April 2004. To
estimate a prevalence of 10% with
accuracy±2%, a sample size of 1,000
was required. Statistical analyses were
carried out in Heidelberg using SAS 9.1
Windows (Cary, NC).
The interviewed cohorts are charac-
terized in Table 1a and the subgroups
with PLE features in Table 1b. A
response rate of 490% was achieved
at each center, with an overall total of
6,895 respondents (62.8% women,
37.2% men). Of 6,836 subjects with
complete questionnaires, 1,235 gave a
history consistent with PLE, giving a
suspected lifetime prevalence of PLE of
18% in the study population (18.2%
after age and sex standardization). A
similar age and sex-standardized pre-
valence (range 17–19.5%), was found
among centers, apart from a low pre-
valence of 13.6% in Turku.
PLE rashes were reported to occur
during springtime by equal proportions
of the total interviewed population per
country (between 7 and 10%), without
indication of a latitudinal gradient
(Table 1b). Frequency of PLE during
sunny holidays in the total population
was strikingly low among Finnish parti-
cipants (9%), compared with other
countries (14–20%), explaining the
overall low prevalence of PLE in Fin-
land. Among people with PLE, theAbbreviations: PLE, polymorphic light eruption
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majority (76–93%) suffered from the
rashes during sunny holidays.
The overall lifetime age-standar-
dized prevalence of PLE among women
was 22.2% (crude prevalence 23.3%),
more than double the 9.8% (9.2%)
found in men. However, a high pre-
valence of PLE among men was found
in Athens (16.6%), resulting in a low
female/male ratio (1.3) compared with
other countries (Table 1b). This may be
explained by a generally higher thresh-
old for clinical expression of PLE in
men, but with the latter approximating
that in women under conditions of
higher UV exposure. People with skin
type I (Fitzpatrick classification) had the
highest prevalence of PLE (33.4% of
women, 28.6% of men), declining in
skin types II (30.8, 15.0%) and III (18.9,
7.0%), with subjects of skin type IV or
higher showing lowest prevalence
(11.2, 4.0 %). Prevalence among differ-
ent skin types showed a significant
trend (Cochran–Armitage trend test;
Po0.001).
Multivariate logistic regression ana-
lysis, entering covariates of country,
skin type, age, and gender simulta-
neously (Table 2), showed that com-
pared with the referent Finland all other
countries had a significantly higher risk
of developing PLE, with the Greek
sample almost three times as likely to
have developed PLE. Higher age was
associated with higher risk of PLE, as
anticipated because of the chronic
nature of the condition. Skin types II,
III, and IV were associated with lower
risk of developing PLE compared with
skin type I, and being female increased
the risk more than threefold.
A further interesting finding of this
study is that skin type distribution
showed little difference between coun-
tries (Table 1a), for example, between
Greece and England, despite known
ethnic differences and anticipated
higher (darker) skin types in Greece.
The proportion of ‘‘easy burners’’ (skin
types I and II) that we found in Greece
is consistent with an earlier study
(Nikolaou et al., 2008). We infer that
in self-appraised skin typing, indivi-
duals will compare themselves with
people around them, that is in
Greece with, on average, darker skin
and also higher sun exposure than in
England. This apparently results in
similar skin type distributions at differ-
ent locations, without any discernible
shifts reflecting basic differences in
ethnicity.
Table 1.
(a) Demographic data of the survey population
Athens,
Greece
Besanc¸on,
France
Heidelberg,
Germany
Leiden, The
Netherlands
Manchester,
UK
Turku,
Finland Total
Participants N 1,263 980 1,634 1,034 984 1,000 6,895
Age in years (mean±SD) 36.7±11.8 28.9±12.4 38.7±10.6 38.1±11.4 38.9±11.3 42.9±11.0 37.5±12.1
Skin type N (%)
I 96 (7.7) 56 (5.8) 26 (1.7) 40 (3.9) 100 (10.8) 52 (5.2) 370 (5.5)
II 341 (27.2) 296 (30.7) 358 (22.8) 284 (27.8) 306 (32.9) 331 (33.2) 1,916 (28.4)
III 661 (52.8) 524 (54.3) 1,090 (69.3) 590 (57.8) 412 (44.4) 546 (54.8) 3,823 (56.8)
XIV 155 (12.4) 89 (9.2) 98 (6.2) 106 (10.4) 111 (11.9) 67 (6.7) 626 (9.3)
Missing data 10 15 62 14 55 4 160
Females N (%)1 744 (59.1) 752 (76.7) 553 (34.8) 491 (58.4) 778 (80.6) 845 (84.5) 4,163 (62.8)1
(b) PLE data
Athens,
Greece
Besanc¸on,
France
Heidelberg,
Germany
Leiden, The
Netherlands
Manchester,
UK
Turku,
Finland
Total
(average %)
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Reporting PLE 273 (19.5) 169 (17.5) 256 (18.9) 201 (17.0) 217 (17.3) 119 (13.6) 1,235 (18.2)
Female/male ratio 1.3 4.0 3.1 3.0 2.2 3.1 2.3
PLE in springtime2 130 (10.3) 64 (6.5) 109 (6.7) 94 (9.1) 65 (6.6) 101 (10.1) 563 (8.2)
PLE during sunny holidays2 240 (19.0) 152 (15.5) 232 (14.2) 179 (17.3) 201 (20.4) 91 (9.1) 1,095 (15.9)
Age of onset of PLE, years
(mean±SD)
27.9±10.4 21.3±11.5 26.2±10.7 22.3±11.2 24.1±10.6 23.9±12.2 24.7±11.2
PLE, polymorphic light eruption.
Percentages are adjusted to standardized age distribution and relate to the whole interviewed population.
1261 missing data on gender.
2PLE reported to occur ‘‘sometimes’’ and ‘‘always.’’
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Apart from the commonly occurring
PLE, idiopathic photodermatoses in-
clude uncommon conditions associated
with more severe symptoms (Holzle
et al., 1987). Photosensitivity also
occurs in rare genetic and biochemical
conditions (Yashar and Lim, 2003), and
can be precipitated by medication. In
this survey, we included questions to
differentiate PLE from other types of
photosensitivity, but cannot exclude
that a limited number of responders
suffered from other photodermatoses.
Hence, PLE is highly prevalent
across Europe, with the highest preva-
lence seen in the most southerly city
sampled (Athens, 19.5%), and the low-
est in the most northerly (Turku,
13.6%). The data for Athens contrast
with a small survey reporting PLE
prevalence of only 3.6% in Ballarat,
Australia (NL 37.51), despite the similar
latitude and skin type distribution
(Pao et al., 1994), and we find no
evidence to support that PLE prevalence
increases toward higher latitudes
with more striking seasonal change in
ambient UVR. Equal proportions of
people report suffering from PLE during
springtime, suggesting that UV radia-
tion is equally sufficient to trigger the
rash in different countries. We propose
that the most southerly dwelling Eur-
opeans who are surveyed are most
affected and display a high prevalence
in both sexes because they reside in a
climate that more easily aggravates the
disease. Our data also indicate that
exposure during sunny holidays
affects the overall prevalence of PLE.
Future studies may focus on the precise
conditions under which PLE occurs
(e.g., sudden or repeated overexpo-
sure); such data could provide clues
on the mechanisms behind disease
provocation.
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Table 2. Multivariable/multivariate logistic regression: adjusted odds
ratios to develop PLE
Variable OR 95% CI P-value
Country
Finland 1
United Kingdom 2.20 1.70–2.84 o0.001
The Netherlands 2.36 1.80–3.10 o0.001
Germany 2.72 2.11–3.52 o0.001
France 2.13 1.62–2.80 o0.001
Greece 2.88 2.25–3.68 o0.001
Age (years)
o20 1
20 to o30 1.87 1.32–2.64 o0.001
30 to o40 2.29 1.62–3.25 o0.001
40 to o50 2.11 1.49–3.01 o0.001
450 2.06 1.43–2.96 o0.001
Skin type
I 1
II 0.80 0.62–1.03 0.09
III 0.39 0.30–0.49 o0.001
IV 0.21 0.15–0.31 o0.001
Gender
Female vs male 3.29 2.78–3.89 o0.001
CI, confidence interval; OR, odds ratio; PLE, polymorphic light eruption.
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